Qualcomm's High-Stakes Licensing Battle: Delaware Trial Confirmed for October 5, 2026
Qualcomm Incorporated (QCOM) continues to navigate a high-stakes legal and operational transition. While the company's stock has faced persistent pressure—trading at $160.75, down 30.9% over the past three months—it is preparing for a landmark trial that will determine the future of its licensing relationship with Arm Holdings plc.
Consolidated Delaware Trial Set for October 5, 2026
In its latest 10-Q filed on July 29, 2026, Qualcomm confirmed that the consolidated trial for its breach of contract claims against Arm Holdings plc and Arm Ltd. is scheduled to begin on October 5, 2026, in the United States District Court for the District of Delaware.
The litigation stems from a series of complaints filed by Qualcomm starting on April 18, 2024, alleging that Arm breached the Qualcomm Architecture License Agreement (ALA) by failing to provide contractually obligated deliverables, improperly seeking to terminate the agreement, and publicizing its termination attempts to damage Qualcomm's business. On June 3, 2025, Qualcomm filed a Second Amended Complaint adding a claim that Arm breached the Qualcomm Technology License Agreement (TLA) by failing to provide license offers at commercially reasonable prices.
On March 30, 2026, Qualcomm amended its consolidated complaint to include an additional claim that Arm breached the Qualcomm ALA by failing to negotiate certain license terms in good faith. In a key pre-trial victory for Qualcomm, the Delaware court denied Arm's motion to strike this amended complaint on July 14, 2026, clearing the way for all claims to be heard in October.
Status of the Original 2022 Litigation
The upcoming October trial is separate from the original 2022 litigation (Arm Ltd. v. Qualcomm Incorporated), which focused on whether Qualcomm breached the Nuvia ALA following its acquisition of Nuvia.
- On December 20, 2024, a Delaware jury delivered a resounding verdict in favor of Qualcomm, finding that Qualcomm did not breach the Nuvia ALA and that its CPUs incorporating Nuvia designs are fully licensed under the existing Qualcomm ALA.
- On September 30, 2025, Judge Maryellen Noreika entered a final judgment upholding the jury's verdict, granting judgment to Nuvia, and dismissing Arm's remaining claims.
- On October 1, 2025, Arm filed a notice of appeal to the U.S. Court of Appeals for the Third Circuit, where the appeal remains pending.
Financial and Operational Context
According to Qualcomm's public market data, the company reported $9.95 billion in revenue for the quarter ending June 30, 2026, marking a 4.0% year-over-year revenue decline and a 23.0% drop in earnings. Despite these headwinds, Qualcomm continues to expand its edge AI and industrial capabilities, recently launching new edge AI solutions featuring the Qualcomm® Dragonwing™ IQ-9075 processor for industrial vision intelligence. The stock's current 52-week position sits at 29.4% (reflecting a 35.7% decline from its 52-week high), indicating that public markets have heavily priced in the litigation uncertainty ahead of the October 5 trial.